Niraparib companion diagnostic - Natera
Latest Information Update: 07 Jan 2022
At a glance
- Originator Natera
- Class Diagnostic agents
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Clinical Phase Unknown Breast cancer